Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources & Third-Party Perspectives
1.3.4. Primary Research
1.3.5. Details of Primary Research
1.4. Information Analysis
1.4.1. Data Analysis Models
1.5. Market Formulation & Data Visualization
1.5.1. Commodity Flow Analysis
1.5.1.1. Approach 1: Commodity flow approach
1.6. Data Validation & Publishing
1.7. Global Market: CAGR Calculation
1.8. List of Secondary Sources
1.9. List of Primary Sources
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.4. Market Restraint Analysis
3.5. Business Environment Analysis
3.5.1. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
3.5.2. Porter’s Five Forces Analysis
3.6. COVID-19 Impact Analysis
Chapter 4. Product Business Analysis
4.1. Stents Market, By Product: Key Takeaways
4.2. Stents Market: Product Movement & Market Share Analysis, 2022 & 2030
4.3. Vascular Stents
4.3.1. Global Vascular Stents Market Estimates and Forecasts, 2018 – 2030 (USD Million)
4.3.2. Coronary Stents
4.3.2.1. Global Coronary Stents Market Estimates and Forecasts, 2018 – 2030 (USD Million)
4.3.3. Peripheral Stents
4.3.3.1. Global Peripheral Stents Market Estimates and Forecasts, 2018 – 2030 (USD Million)
4.3.3.2. Iliac Artery Stents
4.3.3.2.1. Global Iliac Artery Stents Market Estimates and Forecasts, 2018 – 2030 (USD Million)
4.3.3.3. Femoral Artery Stents
4.3.3.3.1. Global Femoral Artery Stents Market Estimates and Forecasts, 2018 – 2030 (USD Million)
4.3.3.4. Carotid Artery Stents
4.3.3.4.1. Global Carotid Artery Stents Market Estimates and Forecasts, 2018 – 2030 (USD Million)
4.3.3.5. Renal Artery Stents
4.3.3.5.1. Global Renal Artery Stents Market Estimates and Forecasts, 2018 – 2030 (USD Million)
4.3.3.6. Other Peripheral Stents
4.3.3.6.1. Global Other Peripheral Stents Market Estimates and Forecasts, 2018 – 2030 (USD Million)
4.3.4. Neurovascular Stents
4.3.4.1. Global Neurovascular Stents Market Estimates and Forecasts, 2018 – 2030 (USD Million)
4.3.4.2. Intracranial Stents
4.3.4.2.1. Global Intracranial Stents Market Estimates and Forecasts, 2018 – 2030 (USD Million)
4.3.4.3. Flow Diverters
4.3.4.3.1. Global Flow Diverters Market Estimates and Forecasts, 2018 – 2030 (USD Million)
4.4. Non-vascular Stents
4.4.1. Global Non-vascular Stents Market Estimates and Forecasts, 2018 – 2030 (USD Million)
4.4.2. Gastrointestinal Stents
4.4.2.1. Global Gastrointestinal Stents Market Estimates and Forecasts, 2018 – 2030 (USD Million)
4.4.2.2. Biliary
4.4.2.2.1. Global Biliary Market Estimates and Forecasts, 2018 – 2030 (USD Million)
4.4.2.3. Duodenal
4.4.2.3.1. Global Duodenal Market Estimates and Forecasts, 2018 – 2030 (USD Million)
4.4.2.4. Colonic
4.4.2.4.1. Global Colonic Market Estimates and Forecasts, 2018 – 2030 (USD Million)
4.4.2.5. Pancreatic
4.4.2.5.1. Global Pancreatic Market Estimates and Forecasts, 2018 – 2030 (USD Million)
4.4.2.6. Esophageal Stents
4.4.2.6.1. Global Esophageal Stents Market Estimates and Forecasts, 2018 – 2030 (USD Million)
4.4.3. Pulmonary (Airway) Stents
4.4.3.1. Global Pulmonary (Airway) Stents Market Estimates and Forecasts, 2018 – 2030 (USD Million)
4.4.3.2. Silicone Airway
4.4.3.2.1. Global Silicone Airway Market Estimates and Forecasts, 2018 – 2030 (USD Million)
4.4.3.3. Metallic Airway
4.4.3.3.1. Global Metallic Airway Market Estimates and Forecasts, 2018 – 2030 (USD Million)
4.4.4. Urological Stents
4.4.4.1. Global Urological Stents Market Estimates and Forecasts, 2018 – 2030 (USD Million)
4.4.5. Others
4.4.5.1. Global Others Market Estimates and Forecasts, 2018 – 2030 (USD Million)
Chapter 5. Material Business Analysis
5.1. Stents Market, By Material: Key Takeaways
5.2. Stents Market: Material Movement & Market Share Analysis, 2022 & 2030
5.3. Metallic Stents
5.3.1. Global Metallic Stents Market Estimates and Forecasts, 2018 – 2030 (USD Million)
5.4. Non-metallic Stents
5.4.1. Global Non-metallic Stents Market Estimates and Forecasts, 2018 – 2030 (USD Million)
Chapter 6. End-Use Business Analysis
6.1. Stents Market, By End-use: Key Takeaways
6.2. Stents Market: End-use Movement & Market Share Analysis, 2022 & 2030
6.3. Hospitals
6.3.1. Global Hospitals Market Estimates and Forecasts, 2018 – 2030 (USD Million)
6.4. Ambulatory Care Centers (ACS)
6.4.1. Global Ambulatory Care Centers (ACS) Market Estimates and Forecasts, 2018 – 2030 (USD Million)
6.5. Specialty Clinics
6.5.1. Global Specialty Clinics Market Estimates and Forecasts, 2018 – 2030 (USD Million)
Chapter 7. Regional Business Analysis
7.1. Regional Market Snapshot
7.2. Market Share Analysis by Country, 2022
7.2.1. North America
7.2.2. Europe
7.2.3. Asia Pacific
7.2.4. Latin America
7.2.5. MEA
7.3. North America
7.3.1. North America Stents Market, 2018 – 2030 (USD Million)
7.3.2. U.S.
7.3.2.1. U.S. Stents Market, 2018 – 2030 (USD Million)
7.3.3. Canada
7.3.3.1. Canada Stents Market, 2018 – 2030 (USD Million)
7.4. Europe
7.4.1. Europe Stents Market, 2018 – 2030 (USD Million)
7.4.2. Germany
7.4.2.1. Germany Stents Market, 2018 – 2030 (USD Million)
7.4.3. UK
7.4.3.1. UK Stents Market, 2018 – 2030 (USD Million)
7.4.4. France
7.4.4.1. France Stents Market, 2018 – 2030 (USD Million)
7.4.5. Italy
7.4.5.1. Italy Stents Market, 2018 – 2030 (USD Million)
7.4.6. Spain
7.4.6.1. Spain Stents Market, 2018 – 2030 (USD Million)
7.4.7. Denmark
7.4.7.1. Denmark Stents Market, 2018 – 2030 (USD Million)
7.4.8. Sweden
7.4.8.1. Sweden Stents Market, 2018 – 2030 (USD Million)
7.4.9. Norway
7.4.9.1. Norway Stents Market, 2018 – 2030 (USD Million)
7.5. Asia Pacific
7.5.1. Asia Pacific Stents Market, 2018 – 2030 (USD Million)
7.5.2. Japan
7.5.2.1. Japan Stents Market, 2018 – 2030 (USD Million)
7.5.3. China
7.5.3.1. China Stents Market, 2018 – 2030 (USD Million)
7.5.4. India
7.5.4.1. India Stents Market, 2018 – 2030 (USD Million)
7.5.5. South Korea
7.5.5.1. South Korea Stents Market, 2018 – 2030 (USD Million)
7.5.6. Australia
7.5.6.1. Australia Stents Market, 2018 – 2030 (USD Million)
7.5.7. Thailand
7.5.7.1. Thailand Stents Market, 2018 – 2030 (USD Million)
7.6. Latin America
7.6.1. Latin America Stents Market, 2018 – 2030 (USD Million)
7.6.2. Brazil
7.6.2.1. Brazil Stents Market, 2018 – 2030 (USD Million)
7.6.3. Mexico
7.6.3.1. Mexico Stents Market, 2018 – 2030 (USD Million)
7.6.4. Argentina
7.6.4.1. Argentina Stents Market, 2018 – 2030 (USD Million)
7.7. MEA
7.7.1. MEA Stents Market, 2018 – 2030 (USD Million)
7.7.2. South Africa
7.7.2.1. South Africa Stents Market, 2018 – 2030 (USD Million)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Stents Market, 2018 – 2030 (USD Million)
7.7.4. UAE
7.7.4.1. UAE Stents Market, 2018 – 2030 (USD Million)
7.7.5. Kuwait
7.7.5.1. Kuwait Stents Market, 2018 – 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Profiles/Listing
8.3.1. Abbott Laboratories
8.3.1.1. Overview
8.3.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.1.3. Product Benchmarking
8.3.1.4. Strategic Initiatives
8.3.2. B. Braun Melsungen AG
8.3.2.1. Overview
8.3.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.2.3. Product Benchmarking
8.3.2.4. Strategic Initiatives
8.3.3. Biotronik SE & Co. KG
8.3.3.1. Overview
8.3.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.3.3. Product Benchmarking
8.3.3.4. Strategic Initiatives
8.3.4. Biosensors International Group, Ltd.
8.3.4.1. Overview
8.3.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.4.3. Product Benchmarking
8.3.4.4. Strategic Initiatives
8.3.5. Boston Scientific Corporation
8.3.5.1. Overview
8.3.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.5.3. Product Benchmarking
8.3.5.4. Strategic Initiatives
8.3.6. Elixir Medical Corporation
8.3.6.1. Overview
8.3.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.6.3. Product Benchmarking
8.3.6.4. Strategic Initiatives
8.3.7. Medtronic Plc
8.3.7.1. Overview
8.3.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.7.3. Product Benchmarking
8.3.7.4. Strategic Initiatives
8.3.8. Meril Life Science
8.3.8.1. Company Overview
8.3.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.8.3. Platform Benchmarking
8.3.8.4. Strategic Initiatives
8.3.9. MicroPort Scientific Corporation
8.3.9.1. Company Overview
8.3.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.9.3. Platform Benchmarking
8.3.9.4. Strategic Initiatives
8.3.10. Stryker
8.3.10.1. Company Overview
8.3.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.10.3. Platform Benchmarking
8.3.10.4. Strategic Initiatives
8.3.11. Terumo Corporation
8.3.11.1. Company Overview
8.3.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.11.3. Platform Benchmarking
8.3.11.4. Strategic Initiatives
8.3.12. BD
8.3.12.1. Company Overview
8.3.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.12.3. Platform Benchmarking
8.3.12.4. Strategic Initiatives
8.3.13. W.L Gore & Associates
8.3.13.1. Company Overview
8.3.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.13.3. Platform Benchmarking
8.3.13.4. Strategic Initiatives